Gynecomastia is a most common condition affecting male breast due to enlargement of both ductal and stromal tissue. Corrective surgery is the only solution for long standing gynecomastia, and it includes open excision, conventional liposuction, or combination of these if required under local (tumescent) or general anaesthesia. Segmental spinal anaesthesia (SSA) to block only the thoracic segments can also be given for breast surgeries and there are numerous advantages such as Avoidance of airway manipulation, polypharmacy, lesser risk of PONV, lesser chances of hypotension, able to achieve adequate muscle relaxation without respiratory or circulatory depression. Using modified tumescent solution (removing lignocaine and bupivacaine) we can eliminate the possibility of Local anaesthesia systemic toxicity (LAST) while analgesia will be provided by SSA. Our Primary objective is to compare the patient satisfaction of using SSA vs GA in patients undergoing liporeduction for gynecomastia surgeries and our secondary Objectives are to assess and compare the surgeon satisfaction of using SSA vs GA in patients undergoing liporeduction for gynecomastia surgeries, to compare the incidence of PONV among both the groups and to compare the incidence of hemodynamic variations among the groups. This is a pilot study, where we want to find the feasibility of using the modified tumescent solution. We will include 20 patients in SSA and 20 patients in GA group. Hence, we would like to compare patient satisfaction with thoracic segmental spinal Anaesthesia using modified tumescent solution vs General Anaesthesia using standard tumescent solution for liporeduction of gynecomastia.